| Financial Year |
March 31 2023 |
| Monetary Funds |
692,655,181.65 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
319,840,260.01 |
| Advances to Suppliers |
9,126,400.60 |
| Other Receivables |
3,615,722.44 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
2,344,319,660.66 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
55,262,083.37 |
| Total Current Assets |
3,495,057,604.32 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
190,934,682.58 |
| Fixed Assetes |
62,467,548.40 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
-- |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
-- |
| Deferred Income Tax Assets |
96,357,109.89 |
| Other Non-Current Assets |
4,855,467.49 |
| Sub-Total of Non-Current Assets |
354,614,808.36 |
| Total Assets |
3,849,672,412.68 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
497,222,010.52 |
| Accounts Received In Advance |
6,664,814.53 |
| Employee Compensation Payable |
378,368.82 |
| Taxes Payable |
35,706,924.11 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
708,295,482.50 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
-- |
| Other Current Liabilities |
39,244,148.10 |
| Sub-Total of Current Liabilities |
1,506,550,333.60 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
-- |
| Total Liabilities |
1,506,550,333.60 |
| Paid-In Capital(Or Share Stock) |
830,003,232.00 |
| Capital Surplus |
343,387,345.38 |
| Surplus Reserve |
40,470,702.21 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
1,052,115,638.62 |
| Minority Stockholder's Interest |
77,145,160.87 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,265,976,918.21 |
| Owner's Equity（Stockholder's Equity） |
2,343,122,079.08 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
3,849,672,412.68 |
